Spallanzani

(redirected from Lazzaro Spallanzani)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Lazzaro Spallanzani: John Needham

Spal·lan·za·ni

(spahl-ahn-zahn'ē),
Lazaro, Italian priest and scientist, 1729-1799. See: Spallanzani law.
References in periodicals archive ?
Author affiliations: Lazzaro Spallanzani National Institute for Infectious Diseases, Rome, Italy (L.
The Lazzaro Spallanzani Institute for Research and Health Care was supported by the European Union Horizon 2020 Research and Innovation Programme (EVIDENT, grant no.
Agfa HealthCare announces that it is implementing a high redundancy, high availability Elefante radiology information system (RIS) and IMPAX picture archiving and communication system (PACS) for the Lazzaro Spallanzani National Institute for Infectious Diseases (Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani I.
Concluding this examination of the eighteenth century is an essay on the viaggio scientifico, which treats several writers but emphasizes the travels of the biologist Lazzaro Spallanzani.
Dr Garbuglia is a senior scientist at the virology laboratory of the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome.
Address for correspondence: Giuseppe Ippolito, Scientific Director, National Institute for Infectious Diseases Lazzaro Spallanzani, Via Portuense 292, 00149 Rome, Italy; email: giuseppe.
Participants: GNA Biosolutions GmbH (Germany) (coordinator), Emergency ONG Onlus (Italy), Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, IRCCS (Italy), Mendel University in Brno (Czech Republic)
Driven by the ambitious objective to quickly detect the Ebola virus in the blood at a very early stage to minimize further transmission, STMicroelectronics and Clonit, in collaboration with Italy s National Institute for Infectious Diseases Lazzaro Spallanzani, have developed, in a few weeks time, a prototype portable analyzer able to identify the presence of the Ebola virus in less than 75 minutes.
Dr Nicastri is an infectious disease physician at the National Institute for Infectious Diseases IRCCS Lazzaro Spallanzani in Rome, Italy.
Since April, we have been working on a clinical study in Italy utilizing the VeriChip healthcare application at the Instituto Nazionale Lazzaro Spallanzani Hospital in Rome.
Vincenzo Puro, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Rome, Italy